Funding for Cancer Research Trainees

How are we doing? Send us your suggestions! Please let us know how we can improve this page, the newsletter, or anything else related to funding opportunity dissemination. 

Rolling Deadlines

Rolling: Siteman Trainee Travel Award

Additional Details

RFP Snapshot: The Siteman Trainee Travel Award supports scholars in career development related to cancer research or cancer health disparities research by providing reimbursement (i.e. registration, airfare, hotel, etc.) to present research at conferences and/or attend workshops/trainings. Scholars who are Underrepresented in Medicine (URiM) and/or women are strongly encouraged to apply.

Eligibility: Applicants must be pre- or post-doctoral trainees affiliated with an SCC investigator. Conference location must be within the domestic USA (includes Canada, Mexico, and US Territories). Application may supplement, but must not duplicate, funding already awarded.

Rolling Due Dates

Rolling: AACR Scholar-in-Training Awards: Other Conferences and Meetings

Additional Details

RFP Snapshot: The AACR offers Scholar-in-Training Awards to enhance the education and training of early career scientists by providing financial support for their attendance at AACR conferences and meetings. The number of awards available, award amounts, and application requirements vary by conference. Please visit the meetings and workshops calendar for a list of upcoming programs and details on financial support available.

Eligibility: Applicants who submit abstracts must be AACR members in good standing. Nonmembers should submit a Membership Application Form.

Rolling Due Dates

February Deadlines

February 29: AACR Clinical Oncology Research (CORE) Training Fellowships - American Association for Cancer Research

Additional Details

RFP Snapshot: The AACR Clinical Oncology Research (CORE) Training Fellowships Program is designed to provide an industry-academic clinical practicum with a unique opportunity for academic clinicians to train in drug development. Each fellowship provides $100,000 over one year for the fellow to work on site at the facility of one of the AACR’s pharmaceutical industry partners: AstraZeneca (Gaithersburg, MD) or Johnson & Johnson (Boston, MA or Philadelphia, PA – Final location TBD).

AstraZeneca – Early- and late-stage clinical development including, but not limited to, antibody drug conjugates, immunotherapy, and cell therapy.

Johnson & Johnson – Early-stage clinical development program aiming to intercept lung cancers in a high-risk population.

Max Amount and Period: $100,000 for 1 year

Eligibility: Applicants must be AACR members. Nonmembers can apply for membership online. Applicant must 1) have a medical degree and not currently be a candidate for a further doctoral degree and 2) have enrolled in an accredited hematology/oncology program at an academic, medical, or research institution within the United States. For the Johnson & Johnson grant ONLY, applicants MUST be female OR belong to one of the underrepresented groups as per NIH guidelines.

Due Date: February 29, 2024 at 4PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

March Deadlines

March 1: CRI Irvington Postdoctoral Fellowship to Promote Racial Diversity - Cancer Research Institute

Additional Details

RFP Snapshot: The CRI Irvington Postdoctoral Fellowship to Promote Racial Diversity supports qualified young scientists from underrepresented minorities at leading universities and research centers around the world who wish to receive training in fundamental immunology and cancer immunology. CRI seeks hypothesis-driven, mechanistic studies in both immunology and tumor immunology that aim to directly impact our understanding of the immune system’s role in cancer.

Max Amount and Period: $243,000 over 3 years

Eligibility: Applicants must identify as Black or African American, Hispanic or Latino, American Indian or Alaska Native, Native Hawaiian, or other Pacific Islander. CRI also recognizes that underrepresentation can vary from setting to setting; individuals from socioeconomically disadvantaged populations and from other racial or ethnic groups that can be demonstrated convincingly to be underrepresented by the grantee institution are encouraged to apply. Both U.S. and non-U.S. citizens are eligible. Applicants must have a doctoral degree by the date of award and conduct their research under a sponsor at the level of Assistant Professor or higher. Applicants must also have less than 5 years of relevant postdoctoral experience at the time of award activation, with the exception of MD applicants.

Due Date: March 1, 2024 at 4PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

March 4 LOI: LCRF Leading Edge Research Grant Program - Lung Cancer Research Foundation

Additional Details

RFP Snapshot: The goal of the 2024 LCRF Leading Edge Research Grant Program is to fund innovative projects across the full spectrum of basic, translational, clinical, epidemiological, health services, early detection, disparities, and social determinants of health research.

Max Amount and Period: $150,000 over 2 years

Eligibility: Applicants must be post-doctoral researchers, clinical fellows, or early-career and mid-career investigators with less than ten years’ experience since their initial faculty appointment. Applicants are prohibited from applying if they have received funding from the LCRF within the last 4 years. Senior investigators with more than ten years’ experience since faculty appointment are generally not eligible for funding and are encouraged to mentor a junior team member through the application process.

Due Date: Letter of Intent Due: March 4, 2024

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

March 4 LOI: LCRF Minority Career Development Award (CDA) in Lung Cancer - Lung Cancer Research Foundation

Additional Details

RFP Snapshot: The LCRF Minority Career Development Award (CDA) for Lung Cancer is a two-year career development award intended to support early-stage scientists from underrepresented groups working in lung cancer and working in diverse areas of research including basic, clinical, translational, disparities, and social determinants of health research. The objective of this award is to increase the number of highly skilled and trained researchers from groups that are historically underrepresented in academia, medicine, and leadership in lung cancer research.

Max Amount and Period: $150,000 over 2 years

Eligibility: Investigators must be from racial or ethnic groups that are underrepresented in health-related sciences and biomedical research. This includes Blacks or African Americans, Hispanics or Latinos, American Indians or Alaskan Natives, Native Hawaiians and other Pacific Islanders. Individuals from racial or ethnic groups that can demonstrate convincingly that they are underrepresented by the host institution will also be eligible. Applicants must be post-doctoral researchers, clinical fellows, or early-career and mid-career investigators within 10 years of receiving their MD and/or Ph.D. However, exceptions will be made for investigators with more than ten years’ experience in other disease areas or topics. Exceptions may also be made for those who did training outside the US. Applicants are prohibited from applying if they have received funding from the LCRF within the last 4 years.

Due Date: Letter of Intent Due: March 4, 2024

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

March 4 LOI: LCRF Research Grant on Early-Detection and Pre-Neoplasia in Lung Cancer - Lung Cancer Research Foundation

Additional Details

RFP Snapshot: This funding mechanism is focused on identifying, characterizing, and developing approaches and techniques that will allow early detection and/or prevention of lung cancer and gaining insight into pre-neoplastic processes in the lungs. The ultimate goal is to detect lung cancer at the earliest stages and subsequently increase survival and survivorship.

Max Amount and Period: $150,000 over 2 years

Eligibility: Applicants must be post-doctoral researchers, clinical fellows, or early-career and mid-career investigators with less than ten years’ experience since their initial faculty appointment. Applicants are prohibited from applying if they have received funding from the LCRF within the last 4 years. Senior investigators with more than ten years’ experience since faculty appointment are generally not eligible for funding and are encouraged to mentor a junior team member through the application process. However, exceptions will be made for investigators with more than ten years’ experience in other disease areas or topics.

Due Date: Letter of Intent Due: March 4, 2024

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

March 4 LOI: LCRF Research Grants on Understanding Resistance in Lung Cancer - Lung Cancer Research Foundation

Additional Details

RFP Snapshot: This grant mechanism will focus on understanding the development, prevention, and therapy of resistance by supporting projects that are identifying, characterizing, treating or preventing resistance to therapies in lung tumor cells, tissues, mouse models, and/or patients. Work supported through this mechanism will address important mechanistic questions and developmental therapeutics across histological subtypes of lung cancer (including lung adenocarcinoma, squamous cell carcinoma and small cell lung cancer) and across the care continuum including newly designed targeted therapies and immunotherapies. These studies will enhance the momentum of improving lung cancer outcomes and have the potential to increase survivorship.

Max Amount and Period: $150,000 over 2 years

Eligibility: Applicants must be post-doctoral researchers, clinical fellows, or early-career and mid-career investigators with less than ten years’ experience since their initial faculty appointment. Applicants are prohibited from applying if they have received funding from the LCRF within the last 4 years. Senior investigators with more than ten years’ experience since faculty appointment are generally not eligible for funding and are encouraged to mentor a junior team member through the application process. However, exceptions will be made for investigators with more than ten years’ experience in other disease areas or topics.

Due Date: Letter of Intent Due: March 4, 2024

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

March 7: RWJF Health Policy Research Scholars - Robert Wood Johnson Foundation

Additional Details

RFP Snapshot: The program is focused on doctoral students who want to improve health, well-being, and equity; challenge longstanding, entrenched systems; exhibit new ways of working; collaborate across disciplines and sectors; and bolster their leadership skills. By providing training in health policy, how to think strategically, and how to craft an actionable research question that can inform solutions to advance health equity—as well as mentorship, career and leadership coaching—HPRS will develop a new community of research leaders who will build a Culture of Health in their disciplines and communities. Up to 40 scholars will be selected for the 2024 cohort.

Max Amount and Period: $120,000 over 4 years

Eligibility: Applicants must be starting full-time, second-year doctoral studies in fall 2024 at a degree-granting institution based in the United States or its territories. Applicants must remain full time while enrolled in HPRS; Applicants must have at least three academic years remaining in their doctoral program and not expect to graduate before spring/summer 2027; Applicants must be from historically marginalized backgrounds and be able to describe how their background, identity, or lived experiences have positioned them to contribute to the goals of the program. Examples of marginalized backgrounds include, but are not limited to, first-generation college graduates; individuals from lower socioeconomic backgrounds; individuals from communities of color; and individuals with disabilities. If an applicant is applying because they have a marginalized background not listed above, the applicant must clearly describe how they meet the eligibility criteria in the application form.

Due Date: March 7, 2024 at 2PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Optional Pre-Application Webinar on 1/25/2024 at noon CST. Register here: https://jh.zoom.us/webinar/register/WN_Aag6ClBRSpSaXvQl64aOPA#/registration

March 14: Frist Family Endowed Young Investigator Award in Mantle Cell Lymphoma in Honor of Howard A. Burris, III, MD - Conquer Cancer, The ASCO Foundation

Additional Details

RFP Snapshot: The Conquer Cancer – Frist Family Endowed Young Investigator Award (YIA) in Mantle Cell Lymphoma (MCL) provides funding to promising investigators to encourage and promote quality research in clinical oncology with a focus on mantle cell lymphoma. The purpose of this endowed YIA award is to fund physicians during the transition from a fellowship program to a faculty appointment. This is a mentored award and the research project is conducted under the guidance of a scientific mentor. Applications are accepted from U.S. and international applicants.

Max Amount and Period: $50,000 for 1 year

Eligibility: Be a physician (MD, DO, or international equivalent) working in any country and currently in the last two years of their final oncology subspecialty training at an academic medical institution and within 10 years of obtaining their medical degree at the time of grant submission. Applicant must be planning an investigative career in clinical oncology with a focus on mantle cell lymphoma. Applicant must also be an ASCO member and be able to commit at least 60% of full-time effort in total research.

Due Date: March 14, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

March 14: Dr. Jose Leis Endowed Young Investigator Award in Chronic Lymphocyic Leukemia - Conquer Cancer, The ASCO Foundation

Additional Details

RFP Snapshot: The Conquer Cancer – Dr. Jose Leis Endowed Young Investigator Award (YIA) in Chronic Lymphocytic Leukemia provides funding to promising investigators to encourage and promote quality research in clinical oncology with a focus on chronic lymphocytic leukemia. The purpose of this award is to fund physicians during the transition from a fellowship program to a faculty appointment. This is a mentored award and the research project is conducted under the guidance of a scientific mentor. Applications are accepted from U.S. and international applicants.

Max Amount and Period: $50,000 for 1 year

Eligibility: Be a physician (MD, DO, or international equivalent) working in any country and currently in the last two years of their final oncology subspecialty training at an academic medical institution and within 10 years of obtaining their medical degree at the time of grant submission. Applicant must be planning an investigative career in clinical oncology with a focus on chronic lymphocytic leukemia. Applicant must also be an ASCO member and be able to commit at least 60% of full-time effort in total research.

Due Date: March 14, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

March 14: BCRF Young Investigator Award for Diveristy and Inclusion in Breast Cancer Research - Conquer Cancer, The ASCO Foundation and the Breast Cancer Research Foundation

Additional Details

RFP Snapshot: The Conquer Cancer – Breast Cancer Research Foundation Young Investigator Award (YIA) for Diversity and Inclusion in Breast Cancer Research is designed with the primary goal of increasing diversity in the oncology workforce and breast cancer research. The YIA will provide funding to promising investigators who identify as members of racial and/or ethnic groups traditionally excluded in academic medicine and biomedical research. The purpose of this award is to fund physicians during the transition from a fellowship program to a faculty appointment as they seek to build a career in clinical breast cancer research. The YIA is a mentored award, and the research project must be conducted under the guidance of a scientific mentor. Applications are accepted from U.S. and international applicants.

Max Amount and Period: $50,000 for 1 year

Eligibility: Self-identify as a member of a racial and/or ethnic group traditionally excluded in academic medicine according to the AAMC definition (include but are not limited to: American Indian/Alaska Native, Black/African American, Hispanic/Latino, and Native Hawaiian/Other Pacific Islander). Individual demographic information will be requested upon application. Be a physician (MD, DO, or international equivalent) working in any country and currently in the last two years of their final oncology subspecialty training at an academic medical institution and within 10 years of obtaining their medical degree at the time of grant submission. Applicant must also be an ASCO member and be able to commit at least 60% of full-time effort in total research.

Due Date: March 14, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

March 15: Damon Runyon Fellowship Awards

Additional Details

RFP Snapshot: Damon Runyon Postdoctoral Research Fellowships are granted for a four-year term with second-, third- and fourth- year funding contingent upon satisfactory progress reports. Fellows in their first and third years of funding will attend Damon Runyon Fellows’ Retreats designed to foster collaboration and interaction between scientists working in different fields relevant to cancer.

Max Amount and Period: $300,000 over 4 years

Eligibility: Applicants must have completed one or more of the following degrees: MD, PhD, MD/PhD, DDS, DVM, DO.

Level 1 Basic and Physician-Scientists must have received their degrees no more than 18 months prior to the application deadline date. Applicants must not have been in their Sponsors’ labs for more than one year prior to the application deadline date and are expected to devote 100% of their time to Damon Runyon-supported research activities.

Level 2 Physician-Scientists must have completed their residencies and clinical training, must be board eligible in the United States at the start date of the Damon Runyon Fellowship, and be able to devote at least 80% of their time to Damon Runyon-supported research activities. Applicants may apply at any time prior to their initial assistant professorship appointment (or equivalent); postdoctoral fellows, clinical fellows and clinical instructors are eligible to apply. Candidates holding or awarded NIH K awards at the time of application are not eligible to apply. Candidates holding institutional K12 awards may apply, but must turn-back K12 funding if they are awarded a Damon Runyon Fellowship.

Due Date: March 15, 2024 at 3PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

March 18: LOI: NTRF Mentored Research Award - Neuroendocrine Tumor Research Foundation

Additional Details

RFP Snapshot: The NETRF Mentored Award is designed to encourage early career investigators to pursue neuroendocrine tumor research and make a commitment to the field. These proposals typically have two aims that provide work requiring two years to complete.

Max Amount and Period: $100,000 over 2 years

Eligibility: Applicants must have an MD, PhD, MD/PhD and hold a full-time, mentored research position with the title of postdoctoral fellow, clinical research fellow, or equivalent. Applicants must work under the auspices of a mentor at an academic, medical, or research institution within the US or abroad, and should be focused on establishing themselves as experts in neuroendocrine tumor research.

Due Date: Letter of Intent Due: March 18, 2024 at 4PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

March 18: SITC-Merck Cancer Immunotherapy Clinical Fellowship Award - Society for Immunotherapy of Cancer

Additional Details

RFP Snapshot: SITC-Merck Cancer Immunotherapy Clinical Fellowship supports an MD or combined MD/PhD with a vested interest in furthering cancer immunotherapy research and translational immunotherapeutic approaches.

Max Amount and Period: $100,000 for 1 year

Eligibility: Applicants must be within postdoctoral or postgraduate training, or no more than four years from completing such training and must hold a position as a postdoctoral fellow, resident, research scientist, or comparable position. Applicants must have a pre-arranged fellowship mentor, and be a current SITC member in good standing. Domestic and international applicants are welcome to apply.

Due Date: March 18, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

March 18: SITC Diversity, Equity, and Inclusion in Cancer Immunotherapy Fellowship Award - Society for Immunotherapy of Cancer

Additional Details

RFP Snapshot: SITC Diversity, Equity and Inclusion Fellowship supports clinical or translational research in cancer immunotherapy and will be awarded to an MD, PhD or combined MD/PhD who self-identifies racial and ethnic minority status according to the NIH’s guidance on underrepresented populations.

Max Amount and Period: $100,000 for 1 year

Eligibility: Applicants must self-identify racial and ethnic status and the status selected must fall into one of the racial and ethnic groups that have been shown to be underrepresented in biomedical research according to the NIH’s guidance on Underrepresented Populations. The following racial and ethnic groups have been shown to be underrepresented in biomedical research: Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, Native Hawaiians and other Pacific Islanders. Applicants must currently hold an MD, PhD, or MD/PhD and be within postdoctoral or postgraduate training, or no more than four years from completing such training. Applicants must hold a position as a postdoctoral fellow, resident, research scientist, or comparable position. Applicants must have a pre-arranged fellowship mentor, and be a current SITC member in good standing. Domestic and international applicants are welcome to apply.

Due Date: March 18, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

March 18: SITC-Mallinckrodt Pharmaceuticals Adverse Events in Cancer Immunotherapy Clinical Fellowship Award - Society for Immunotherapy of Cancer

Additional Details

RFP Snapshot: SITC-Mallinckrodt Pharmaceuticals Adverse Events in Cancer Immunotherapy Clinical Fellowship supports an individual who has an MD (or equivalent) or combined MD/PhD degree with a vested interest in furthering the research and translation of adverse events in cancer immunotherapy.

Max Amount and Period: $40,000 for 1 year

Eligibility: Applicants must be within postdoctoral or postgraduate training, or no more than four years from completing such training and must hold a position as a postdoctoral fellow, resident, research scientist, or comparable position. Applicants must have a pre-arranged fellowship mentor, and be a current SITC member in good standing. Domestic and international applicants are welcome to apply.

Due Date: March 18, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

March 18: SITC-Bristol Myers Squibb Postdoctoral Cancer Immunotherapy Translational Fellowship Award - Society for Immunotherapy of Cancer

Additional Details

RFP Snapshot: SITC-Bristol Myers Squibb Postdoctoral Cancer Immunotherapy Translational Fellowship Award supports the development of the next generation of immunotherapy experts by providing support for cancer immunotherapy by an individual who has an MD, PhD or combined MD/PhD degree and a vested interest in furthering the research and translation of cancer immunotherapy.

Max Amount and Period: $200,000 over 2 years

Eligibility: Applicants must be within postdoctoral or postgraduate training, or no more than four years from completing such training and must hold a position as a postdoctoral fellow, resident, research scientist, or comparable position. Applicants must have a pre-arranged fellowship mentor, and be a current SITC member in good standing. Domestic and international applicants are welcome to apply.

Due Date: March 18, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

March 19: Harold Amos Medical Faculty Development Program (AMFDP) - Robert Wood Johnson Foundation

Additional Details

RFP Snapshot: The Harold Amos Medical Faculty Development Program (AMFDP) offers four-year postdoctoral research awards to faculty from historically marginalized backgrounds who can achieve senior rank in academic medicine, dentistry, or nursing. This program supports the development of faculty to enhance their influence as leaders, researchers, and advisors in supporting a Culture of Health, in which everyone has the chance to live the healthiest life possible.

Max Amount and Period: $420,000 over 4 years

Eligibility: Applicants must be from historically marginalized backgrounds and be able to describe how their background, identity, or lived experiences have positioned them to contribute to the goals of the program. Examples of marginalized backgrounds include, but are not limited to, first-generation college graduates; individuals from lower socioeconomic backgrounds; individuals from communities of color; and individuals with disabilities. All applications should be US citizens, permanent residents, or be individuals granted DACA status at the time of application. Applicants must be completing or have completed their formal clinical training and must be able to spend at least 70 percent of their time engaged in research.

Due Date: March 19, 2024 at 2PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

March 20: ASTRO-AAPM Physics Residents/Postdoctoral Fellows Seed Grant - American Society for Radiation Oncology / American Association of Physicists in Medicine

Additional Details

RFP Snapshot: The purpose of this grant is to foster and develop the research careers of postdoctoral fellows and medical physics residents interested in radiation oncology related research.

Max Amount and Period: $25,000 for 1 year

Eligibility: Applicants must hold a PhD or equivalent, be postdoctoral fellows, or medical physics residents, and be employed by a US based eligible institution at the time of application. All applicants must be prepared to commit at least 75% of their full-time professional effort to research. Applicants must be current and active ASTRO and AAPM members, or have applied for membership. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for ASTRO-AAPM support. Multiple PIs are not allowed.

Due Date: March 20, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

March 21: AACR-Ocular Melanoma Foundation Joanne Barlia Research Fellowship - American Association for Cancer Research

Additional Details

RFP Snapshot: The AACR-Ocular Melanoma Foundation Joanne Barlia Research Fellowship represents a joint effort to encourage and support a postdoctoral or clinical research fellow to conduct ocular/uveal melanoma research and to establish a successful career path in ophthalmology, ocular oncology, uveal melanoma biology, or a similar field. The research proposed for funding must be translational or clinical in nature and must have direct, primary applicability and relevance to ocular/uveal melanoma.

Max Amount and Period: $130,000 over 2 years

Eligibility: Applicants must have a doctoral degree in a related field and not be a candidate for a further doctoral degree. At the start of the grant term, applicants must hold a mentored research position with the title of postdoctoral fellow, clinical research fellow, or equivalent and have completed their most recent doctoral degree within the past 5 years. Applicants must be AACR members in good standing. Nonmembers can apply for membership online.

Due Date: March 21, 2024 at Noon CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

March 21: Career Guidance for Trainees (CGT) - Burroughs Wellcome Fund

Additional Details

RFP Snapshot: The workshop will focus on developing participants’ research evaluation skills while creating new career-focused interventions or activities for use at the participants’ home institutions. In the year following the workshop, participants will each develop their research and evaluation networks, run their project with support from a $15,000 grant from the Burroughs Wellcome Fund, submit their results for presentation a national meeting, and produce a rigorously prepared manuscript for publication.

Max Amount and Period: $15,000 for 1 year and career development workshop (5/29-5/31)

Eligibility: Academic administrators whose work is at least 80% focused on career development activities focused on graduate students or postdoctoral fellows at a research-focused institution in the United States or Canada and who have been in this type of role for at least 3 years (36 months) but not more than 7 years (84 months) may apply. This program does not support biomedical research projects proposed by individual investigators.

Due Date: March 21, 2024 at 2PM CST

March 27: LOI: OCRA Mentored Investigator Grant - Ovarian Cancer Research Alliance

Additional Details

RFP Snapshot: This grant (formerly called the Ann Schreiber Mentored Investigator Award) provides funding for trainees who are working under the supervision of a mentor who is a recognized leader in the field of ovarian cancer research, or relevant area.

Max Amount and Period: $100,000 over 1-2 years

Eligibility: Applicants must be either clinical fellows or post-doctoral fellows with protected time to do the work. Applicants must have a MD/DO and/or PhD. Applicants should be involved in either laboratory, clinical, epidemiologic, or health services research and have a mentor. PhD applicants must be no than 5 years out of their terminal degree at time of application (e.g. terminal degree must have been awarded during 2019 or later); MD/DOs and MD/PhDs must be currently enrolled in a fellowship program. At least 80% of effort should be devoted to research during the tenure of the grant. International applicants are welcome to apply.

Due Date: Letter of Intent Due: March 27, 2024 at 4PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

March 31: Breast Cancer Alliance Exceptional Project Grants

Additional Details

RFP Snapshot: Breast Cancer Alliance invites clinical doctors and research scientists at any stage of their careers, including post docs, whose current proposal is focused on breast cancer, to apply for an Exceptional Project Grant. This award recognizes creative, unique and innovative research.

Max Amount and Period: $100,000 for 1 year

Eligibility: Applicants may be clinical doctors or research scientists at any stage in their careers, including post docs. Applicants may only submit an LOI for either the Exceptional Project Grant OR the Young Investigator Grant.

Due Date: March 31, 2024

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

March 31: Breast Cancer Alliance Young Investigator Grants

Additional Details

RFP Snapshot: To encourage a commitment to breast cancer research, Breast Cancer Alliance invites clinical doctors and research scientists who are in the early stages of their careers, including post docs, whose current proposal is focused on breast cancer, to apply for funding for the Young Investigator Grant.

Max Amount and Period: $125,000 over 2 years

Eligibility: Applicants may be clinical doctors or research scientists at any stage in their careers, including post docs. Applicants may only submit an LOI for either the Exceptional Project Grant OR the Young Investigator Grant.

Due Date: March 31, 2024

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

April Deadlines

April 1: ACS Postdoctoral Fellowships - American Cancer Society

Additional Details

RFP Snapshot: Postdoctoral Fellowships (PF) support new investigators in research training programs to to position them for independent careers in cancer research. As part of their evaluation, peer reviewers consider how well the fellowship will broaden the applicant’s research training and experience.

Special Focus Opportunity: The ACS is offering an area of special focus for the postdoctoral fellowship this year to support mind-body-spirit wellness in cancer survivors (HEALED).

Max Amount and Period: $204,000 over 3 years

Eligibility: Applicants must have had their doctoral degrees for less than 4 years; time spent in clinical-only training is not counted. Applicants must not have a faculty appointment.

Due Date: April 1, 2024 at 10:59PM CST

Virtual Webinar (90 min): February 28, 2024 at 1PM CST – Register today for webinar on grantsmanship and current ACS funding opportunities. Link to register: https://us06web.zoom.us/meeting/register/tZArd-qprjMqGNwfHoN7a6NK1dYUNvf2DgLP#/registration

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

April 11: AACR-Exelixis Renal Cell Carcinoma Research Fellowship - American Association for Cancer Research

Additional Details

RFP Snapshot: The AACR-Exelixis Renal Cell Carcinoma Research Fellowship represents a joint effort to encourage and support a postdoctoral or clinical research fellow to conduct renal cell carcinoma research and to establish a successful career path in this field. The research proposed for funding may be in basic, translational, clinical, or population sciences research and must have direct applicability and relevance to renal cell carcinoma.

Max Amount and Period: $130,000 over 2 years

Eligibility: Applicants must have a doctoral degree in a related field and not be a candidate for a further doctoral degree. At the start of the grant term, applicants must hold a mentored research position with the title of postdoctoral fellow, clinical research fellow, or equivalent and have completed their most recent doctoral degree within the past 5 years. Applicants must be AACR members in good standing. Nonmembers can apply for membership online.

Due Date: April 11, 2024 at Noon CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

April 15: 2024 PCF Young Investigator Awards - Prostate Cancer Foundation

Additional Details

RFP Snapshot: PCF seeks applications from the global biomedical research community. Applicants traditionally under-represented in science and medicine are highly encouraged. We seek applications from early-career basic scientists, medical oncologists, pathologists, urologists, radiologists, radiation oncologists, public health experts, bioinformaticians, bioengineers, or professionals from any other field that could contribute to the end of potentially lethal prostate cancer. Applicants may be working in basic, translational, computational or clinical research and need not be trained specifically in prostate cancer research to be highly competitive. However, successful applicants should be working in an academic research environment capable of supporting transformational prostate cancer research. Access to and real-time interaction with a clinical environment and translational prostate cancer physician-scientists is highly desired. PCF especially encourages young investigators working on prostate cancer health disparities to apply.

Max Amount and Period: $225,000 over 3 years

Eligibility: Applicants must be within 6 years following completion of degree and most hold the title of Postdoctoral Fellow, Instructor, Research Associate, Assistant Professor, or equivalent. At least one mentor must be involved. Applicant should not hold grant commitments exceeding $1,000,000 in direct research funding from all sources including institutional funds at the time of application.

Due Date: April 15, 2024 at 2PM CST

Application Assistance: Washington University faculty may reach out to Sarah Van Vickle-Chavez in Public Health Sciences at [email protected] with any questions and for assistance with the proposal, including gathering pertinent catchment statistics regarding disparities.

Washington University faculty may also reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

April 16: AACR Cancer Disparities Research Fellowship - American Association for Cancer Research

Additional Details

RFP Snapshot: The AACR Cancer Disparities Research Fellowships represent an effort to encourage and support postdoctoral or clinical research fellows to conduct cancer disparities research and to establish a successful career path in this field. The proposed research may be in basic, translational, clinical, or population sciences research and must have direct applicability and relevance to cancer disparities.

Max Amount and Period: $130,000 over 2 years

Eligibility: Applicants must have a doctoral degree in a related field and not be a candidate for a further doctoral degree. At the start of the grant term, applicants must hold a mentored research position with the title of postdoctoral fellow, clinical research fellow, or equivalent and have completed their most recent doctoral degree within the past 5 years. Applicants must be AACR members in good standing. Nonmembers can apply for membership online.

Application Assistance: Washington University faculty may reach out to Sarah Van Vickle-Chavez in Public Health Sciences at [email protected] with any questions and for assistance with the proposal, including gathering pertinent catchment statistics regarding disparities.

Washington University faculty may also reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

May Deadlines

May 1: LOI: PhRMA Predoctoral Fellowship in Drug Discovery - The PhRMA Foundation

Additional Details

RFP Snapshot: The PhRMA Foundation Predoctoral Fellowship in Drug Discovery Targets and Pathways provides support for promising students (U.S. and non-U.S. citizens) in advanced stages of training and thesis research in drug discovery research. The PhRMA Foundation seeks to fund novel early-stage, exploratory drug discovery research with the potential for translation to humans, including biological validation of potential drug targets, signaling pathways, or mechanisms of disease.

Max Amount and Period: $30,000 – $60,000 over 1-2 years

Eligibility: Applicants will have completed most of their pre-thesis requirements (at least two years of coursework) and be engaged in thesis research as PhD candidates by the time the award is activated. Award activation can begin as early as January 1, 2025, or as late as August 1, 2025. Applicants should expect to complete their PhD requirements in two years or less from the time funding begins. Applicants who expect to complete their PhD before December 31, 2025, are not eligible. Applicants enrolled in MD/PhD programs should not be engaged in required clinical coursework or clerkships while the fellowship is active. Fellows are expected to devote full time (including summers) to their research. Predoctoral fellowships should not be seen as a way to fund the principal investigator’s currently funded research project. No citizenship requirements.

Due Date: May 1, 2024 at 11AM CST

May 1: LOI: PhRMA Predoctoral Fellowship in Drug Delivery - The PhRMA Foundation

Additional Details

RFP Snapshot: The PhRMA Foundation Predoctoral Fellowship in Drug Delivery provides support for promising students (U.S. and non-U.S. citizens) in advanced stages of training and thesis research in drug delivery research, including basic pharmaceutics, biopharmaceutics, pharmaceutical technology, pharmaceutical biotechnology, or biomedical engineering. Research that focuses on findings that can be generalized to other systems will be prioritized.

Max Amount and Period: $30,000 – $60,000 over 1-2 years

Eligibility: Applicants will have completed most of their pre-thesis requirements (at least two years of coursework) and be engaged in thesis research as PhD candidates by the time the award is activated. Award activation can begin as early as January 1, 2025, or as late as August 1, 2025. Applicants should expect to complete their PhD requirements in two years or less from the time funding begins. Applicants who expect to complete their PhD before December 31, 2025, are not eligible. Applicants enrolled in MD/PhD programs should not be engaged in required clinical coursework or clerkships while the fellowship is active. Fellows are expected to devote full time (including summers) to their research. Predoctoral fellowships should not be seen as a way to fund the principal investigator’s currently funded research project. No citizenship requirements.

Due Date: May 1, 2024 at 11AM CST

May 1: LOI: PhRMA Postdoctoral Fellowship in Drug Discovery - The PhRMA Foundation

Additional Details

RFP Snapshot: The PhRMA Foundation Postdoctoral Fellowship in Drug Discovery supports individuals (U.S. and non-U.S. citizens) engaged in a multidisciplinary, collaborative research training program at an accredited U.S. university that will extend their credentials in drug discovery research. The PhRMA Foundation seeks to fund novel early-stage, exploratory drug discovery research with the potential for translation to humans, including biological validation of potential drug targets, signaling pathways, or mechanisms of disease.

Max Amount and Period: $60,000 – $120,000 over 1-2 years

Eligibility: Applicants must be within their first three years of postdoctoral training at the time of award activation. An ideal candidate will be conducting their research in a new laboratory and not where their graduate work was performed. Applicants must hold a PhD, PharmD, MD, or appropriate terminal research doctorate. If applicant does not hold one at the time of submission, they will need to state when they expect to receive it, as it must be received before funding can begin. Funding can begin as early as January 1, 2025, or as late as August 1, 2025. No citizenship requirements.

Due Date: May 1, 2024 at 11AM CST

May 1: LOI: PhRMA Postdoctoral Fellowship in Drug Delivery - The PhRMA Foundation

Additional Details

RFP Snapshot: The PhRMA Foundation Postdoctoral Fellowship in Drug Delivery supports individuals (U.S. and non-U.S. citizens) engaged in a multidisciplinary, collaborative research training program at an accredited U.S. university that will extend their credentials in drug delivery research, including basic pharmaceutics, biopharmaceutics, pharmaceutical technology, pharmaceutical biotechnology, or biomedical engineering. Research that focuses on findings that can be generalized to other systems will be prioritized.

Max Amount and Period: $60,000 – $120,000 over 1-2 years

Eligibility: Applicants must be within their first three years of postdoctoral training at the time of award activation. An ideal candidate will be conducting their research in a new laboratory and not where their graduate work was performed. Applicants must hold a PhD, PharmD, MD, or appropriate terminal research doctorate. If applicant does not hold one at the time of submission, they will need to state when they expect to receive it, as it must be received before funding can begin. Funding can begin as early as January 1, 2025, or as late as August 1, 2025. No citizenship requirements.

Due Date: May 1, 2024 at 11AM CST

May 1: LOI: PhRMA Postdoctoral Fellowship in Translational Medicine - The PhRMA Foundation

Additional Details

RFP Snapshot: The PhRMA Foundation’s Postdoctoral Fellowship in Translational Medicine supports individuals (U.S. and non-U.S. citizens) engaged in a multidisciplinary, collaborative research training program at an accredited U.S. university that will extend their credentials in translational medicine. This program focuses specifically on novel research that uses the “bedside to bench” approach to address unmet needs in the diagnosis, treatment, and prevention of disease. The Foundation seeks research proposals that focus on identifying unmet clinical needs and developing new diagnostic, experimental, and computational approaches and technologies to improve patient care and management.

Max Amount and Period: $60,000 – $120,000 over 1-2 years

Eligibility: Applicants must be within their first three years of postdoctoral training at the time of award activation. An ideal candidate will be conducting their research in a new laboratory and not where their graduate work was performed. Applicants must hold a PhD, PharmD, MD, or appropriate terminal research doctorate. If applicant does not hold one at the time of submission, they will need to state when they expect to receive it, as it must be received before funding can begin. Funding can begin as early as January 1, 2025, or as late as August 1, 2025. No citizenship requirements.

Due Date: May 1, 2024 at 11AM CST

May 15: Emerging Scientist Grant - Kids Beating Cancer

Additional Details

RFP Snapshot: The Emerging Scientist Grant aims to develop graduate students into tomorrow’s scientific leaders by providing grants to students pursuing a future career in pediatric cancer research. The Emerging Scientist Grant is designed for graduate students pursuing a master’s degree, PhD, or medical degree.

Max Amount and Period: $10,000 for 1 year

Eligibility: Applicant must be a grad student pursuing their master’s, PhD, or medical degree. Must work with a mentor and work in the field of pediatric oncology in the US.

Due Date: May 15, 2024

This newsletter is not fully inclusive of all available cancer-related funding for trainees.

Please be sure to consult other sources to learn of other opportunities not listed above.